Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$6.67 - $9.8 $6,670 - $9,800
-1,000 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$5.64 - $23.33 $5,640 - $23,330
1,000 New
1,000 $6,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.